Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

This study is testing whether a combination pill of atorvastatin (a statin) and omega-3 fatty acids can slow carotid artery plaque buildup in people with type 2 diabetes who have mixed cholesterol abnormalities and are already on a moderate-intensity statin. **You may be eligible if...** - You are 20 or older with type 2 diabetes on treatment (HbA1c between 6.0–10.0%) - You have mixed dyslipidemia despite already being on a moderate-intensity statin: triglycerides at or above 200 mg/dL, low HDL, and LDL above 100 mg/dL - You have confirmed carotid artery plaque on imaging (intima-media thickness of 1.0 mm or more) - You are asymptomatic with no history of heart attack, stroke, or coronary artery procedures **You may NOT be eligible if...** - You have had a prior heart attack, stroke, or chest pain episodes - You have significant kidney or liver disease - You are pregnant or a woman of childbearing potential not using contraception - You have a known allergy to statins or omega-3 medications Talk to your doctor to see if this trial is right for you.